Active, not recruitingNCT03661866
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Target PharmaSolutions, Inc.
- Principal Investigator
- Laura DalfonsoTarget RWE
- Enrollment
- 15000 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2050
Study locations (30)
- Clear Dermatology & Aesthetics Center/Investigative MD, Scottsdale, Arizona, United States
- Johnson Dermatology, Fort Smith, Arkansas, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Arkansas Dermatology, Little Rock, Arkansas, United States
- First OC Dermatology, Fountain Valley, California, United States
- Center for Dermatology Cosmetic and Laser Surgery, Fremont, California, United States
- University of California, Irvine, California, United States
- University of California - San Diego/Rady Children's Hospital, San Diego, California, United States
- George Washington University, Washington D.C., District of Columbia, United States
- Feinstein Dermatology and Cosmetic Surgery, Hollywood, Florida, United States
- Academic Alliance in Dermatology, Tampa, Florida, United States
- Integrated Dermatology of West Palm Beach, West Palm Beach, Florida, United States
- Lurie Children's Hospital/Northwestern University, Chicago, Illinois, United States
- Dawes Fretzin Dermatology/ Dawes Fretzin Clinical Research Group, Indianapolis, Indiana, United States
- The University of Kansas Medical Center, Kansas City, Kansas, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03661866 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC